- Concord Medical Services Holdings (CCM, Financial) has filed its 2024 annual report on Form 20-F with the SEC.
- The report is available electronically on Concord Medical's and the SEC's websites.
- Shareholders are entitled to receive free hard copies of the audited financial statements.
Concord Medical Services Holdings Limited (CCM), a prominent Chinese healthcare provider specializing in oncology services, has announced the submission of its annual report on Form 20-F for the fiscal year ending December 31, 2024. The filing was made with the U.S. Securities and Exchange Commission (SEC) on April 25, 2025.
The comprehensive annual report is readily accessible on Concord Medical's investor relations portal at ir.ccm.cn and the SEC's website at www.sec.gov. For those preferring a hard copy, the company offers free copies of the audited financial statements upon request, which can be submitted through their investor relations website.
Renowned for its full cycle of advanced cancer care services including diagnosis, treatment, and prevention, Concord Medical continues to focus on improving cancer care quality through its network of self-owned and partnered hospitals across China. The company also employs state-of-the-art technology, such as proton therapy, to enhance treatment outcomes.
